





 The magnitude of opioid abuse has reached epidemic levels as national survey data reveal that 4.5 million people across the country abuse medications intended for pain relief.  Especially hard hit, all counties of southwestern Pennsylvania exceed the state’s mortality rate for deaths due to prescription drugs.  The co-occurrence of substance abuse and homelessness has already been well established.  As the homeless population of Allegheny County has increased, research that indicates drug overdoses have replaced HIV/AIDS as the leading cause of mortality among the homeless, with 80% of drug overdose deaths attributable to opioids, warrants concern.  This article presents a review of treatment options for the homeless population with opioid use disorder which may be feasible to offer before securing housing, based upon recently published literature.  
A search of PubMed was conducted.  It was restricted to English-language articles with human subjects published between 2011 and 2015 that address therapies for opioid related disorders among the homeless.  The term “opioid related disorders” as a MeSH Major Topic yielded 2,620 publications.  The addition of the term “therapy” as a MeSH Subheading restricted the list to 1,901 publications.  Further applying “homeless” as a term to be searched in all fields produced the final list of 15 publications.  Review of these articles for relevance to the stated topic produced three publications for consideration.
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The 2014 National Survey on Drug Use and Health identified that among the estimated 6.5 million people nationwide who use prescription drugs illicitly, 4.5 million, or 70%, are abusing pain relievers ().  While abuse does not always develop into addiction, inappropriate use of prescription opioids carries substantial risks for opioid-related fatalities ().  Specifically in Pennsylvania, mortality related to overdoses increased from 2.7 in 1990 to 15.4 overdose deaths per thousand residents in 2011 ().  Locally, 2011 data from Allegheny County (AC) indicated that 20.5 people per 100,000 residents died from drug overdoses, pointedly increased from 6.3 per 100,000 in 1990 (). The Pittsburgh Post-Gazette identified prescription drug abuse as a particularly troubling in southwestern Pennsylvania, noting that all southwestern Pennsylvania counties exceed death rates across the rest of the state ().  
Harrisburg, capital of the Commonwealth of Pennsylvania, also took notice of the epidemic.  The 2014 report by the Pennsylvania Department of Drug and Alcohol Programs indicated that nearly 16% of the state’s budget, roughly $430 per capita, was spent on untreated or undertreated alcohol and substance abuse problems.  Recognizing the need for action, on October 27, 2014, Pennsylvania Governor Tom Corbett enacted the Achieving Better Care by Monitoring All Prescriptions Act (ABC-MAP) of 2014.  The ABC-MAP Act was designed to provide enhanced prescription drug monitoring in order to curb fraud and abuse.  Among its many supporters, the Pennsylvania Medical Society hailed the law for its potential to help prescribers and dispensers (i.e. pharmacies) detect and stop “doctor shoppers” ().  The law was not so warmly received by all, however.  Echoing previous statements by the Office of National Drug Control Policy (2014), Andy Hoover, Legislative Director American Civil Liberties Union of Pennsylvania, identified this as only part of the solution.  While solutions may include legal and regulatory action, it is time “to put more investment into treatment and start addressing this as a public health issue” ().  
1.1	Homelessness and Substance Abuse
Addressing an epidemic of opioid abuse warrants special consideration of social ecological factors for distinct populations, particularly those already disenfranchised, such as the homeless.  Research by Galea and Vlahov (2002) described how social factors, including socioeconomic status and homelessness, are intertwined with drug use.  The unsettling reality is that between 2010 and 2014, AC witnessed a 25% increase in the homeless population from 1,265 to 1,573 people, as measured by the annual Point-in-Time survey required by the United States Department of Housing and Urban Development ().  While the prevalence of individuals with severe mental illness accounted for the largest subpopulation of the homeless (approximately 40%), the second most prevalent subpopulation was individuals with chronic substance abuse (approximately 30%).
A recent study in Boston demonstrates cause for concern about substance abuse among Pittsburgh’s homeless and reason to approach it as a public health matter.  ) discovered a concerning shift in cause-specific mortality that developed over a 15 year time period within the homeless population.  On the surface, all-cause mortality rates remained unchanged between 1988-1993 and 2003-2008 cohorts of homeless individuals.  Increases in death due to drug overdose, however, were significant enough to make it the leading cause of death, and also offset decreases in HIV/AIDS mortality such that the net effect on all-cause mortality between cohorts was neutral.  Notably, Baggett et al. (2013) found that 80% of overdose deaths were attributable to opioids.  Reexamining their data from the 2003-2008 cohort of 28,000 homeless individuals,  ADDIN EN.CITE ) reported that drug-attributable mortality was 8 to 17 times greater in homeless women and 10 to 14 times greater in homeless men compared to the rest of the population. 
Addressing either homelessness or substance abuse is independently complicated; the combination of the two, however, truly represents a difficult situation.  Choosing which issue to address first presents a logistical challenge; whether it is more feasible to provide treatment for substance abuse while someone remains homeless or to provide housing to someone with known, ongoing substance abuse.  For some time, the solution has been to provide housing assistance conditional upon demonstrated and maintained abstinence  ADDIN EN.CITE (; ).  A substance-free environment may be conducive to achieving and maintaining an addiction-free life for some of the population; however, for many homeless, finding food and shelter is more essential than drug counseling ().  
The housing debate is far from over, however.  Interviews with front-line providers illustrate that strategies and treatment programs accepting of and prepared to address relapse as a harm reduction strategy are more effective than abstinence-only programming ().  Housing First, a program developed by ) and further reported on by ) provides housing to those with mental health or substance abuse conditions without prerequisites for treatment or sobriety.  Their findings suggest people for whom housing is provided immediately, without requirements for abstinence, are equally able to obtain and maintain that housing.
1.2	Opioid pharmacology and Addiction
Addressing a public health problem such as the opioid epidemic also requires awareness of individual-level risk factors.  Understanding the effect prescription and illicit opioids have on neurologic processes provides useful insight on both the development and treatment of addiction.  A variety of neurotransmitters has been implicated in the development of addiction, including serotonergic, opioid, endocannabinoid, GABAergic, and glutamatergic mechanisms ().  The most directly responsible neurotransmitter is dopamine, levels of which are increased in even simple pleasurable experiences.  While research is still seeking to understand the exact mechanisms of opioid addiction, scientific literature widely supports the association between addictive drugs and activation of a common dopamine reward pathway ().  
The connection between addictive pharmacologic opioids and the dopamine reward pathway is understandable; the human body produces natural or endogenous opioids, commonly involved in pain perception, reward, stress and autonomic control ().  Out of the opioid receptor subtypes, stimulation of the mu and delta receptors facilitates the release of dopamine.  The central nervous system responds to repeated mu opioid receptor activation and consequential floods of dopamine with desensitization and adaptive tolerance.  The body may develop tolerance to a variety of non-addictive substances.  Tolerance for addictive substances becomes problematic however as the user requires increasingly greater doses to achieve the desired pain relief or pleasure.  Further use may lead to dependence, characterized as the experience of withdrawal if the drug use is ceased  ADDIN EN.CITE (; ).  At the point that the individual exhibits a cluster of cognitive, behavioral and physiological symptoms and continues to use the substance despite significant substance-related problems, he or she has likely developed a substance use disorder ().  
1.3	Medication-Assisted Treatment
A joint effort between clinicians and the Federal government, Adapting Your Practice: Recommendations for the Care of Homeless Patients with Opioid Use Disorders, recommends the medication-assisted treatment (MAT) be offered to any patient with an opioid use disorder ().  Buprenorphine and methadone are the two most common medications used in MAT for substance use disorders.  Methadone, a synthetically derived opioid, acts as a receptor agonist in that it stimulates the opioid receptors much like prescription opioid analgesics and heroin ().  When given in sufficient doses once daily, the long lasting effects of methadone make it possible to attenuate withdrawal and cravings associated with substance use disorder.  A highly regulated Schedule II substance, the prescription of methadone for treatment of opioid addiction is subject to stringent Federal regulations ().  State governmental agencies may also impose additional requirements for its prescribing and dispensing.
Buprenorphine behaves similarly to methadone; however while methadone is a full mu opioid agonist, buprenorphine is a partial agonist ().  Like methadone, it is also generally given once a day.  Buprenorphine will not activate the mu opioid receptors to the same degree as methadone and thus buprenorphine may be less appropriate for patients with high levels of opioid dependence and tolerance ().  Potential for abuse of buprenorphine is decreased by combining it with the opioid reversal agent naloxone.  When taken orally as instructed, the naloxone has low bioavailability and will not affect the individual.  If, however, an individual attempts to abuse the combined buprenorphine and naloxone product by way of dissolving and injecting it, the naloxone will trigger an antagonistic effect, producing withdrawal symptoms. Listed as a Schedule III substance, buprenorphine is also highly regulated by federal and state agencies.  
Despite the best efforts of public health interventionists, there may be a variety of reasons why a community cannot or will not support the Housing First model ().  Bearing in mind the importance of patient-centered care, from a public health program planning perspective, successful interventions will offer flexible services that can adapt to the needs of individuals in AC, and the AC community itself.  This paper presents a review of treatment options for the homeless population with opioid use disorder which may be feasible to offer before securing housing, based upon recently published literature.

2.0 	Methods
The United States National Library of Medicine’s PubMed electronic database was accessed in October and November of 2015 using different combinations of Medical Subject Headings (MeSH) and subheading search terms.  The search was restricted to English-language articles with human subjects published between 2011 and 2015 that address therapies for opioid related disorders among the homeless.  The term “opioid related disorders” as a MeSH Major Topic yielded 2,620 publications.  The addition of the term “therapy” as a MeSH Subheading restricted the list to 1,901 publications.  Further applying “homeless” as a term to be searched in all fields produced the final list of 15 publications.  
Inclusion criteria for these 15 publications required the article to address the homeless as the population target, as opposed to reported as a demographic with no further analysis; the article had to identify and describe the treatment as well as provide analysis of the outcomes as they related to reducing or eliminating substance use; the substances of abuse had to include opioids or heroin; and the article had to be available to access through the University of Pittsburgh Health Sciences Library System.  Of these 15 articles, two were identified that met all inclusion criteria (Figure 1).  One additional article was obtained and included as it was the foundation for one of the two articles identified through the PubMed search.

Figure 1.  Flowchart of Selection of Peer-Reviewed Articles to Assess Recent (2011-2015) Research on Therapies for Opioid Related Disorders among the Homeless
3.0 	Results
Each of the three final selected publications reported on a program that took place in a different state within the United States.  Each used a unique modality for providing treatment services.  None of the three was provided directly out of a methadone clinic or physician’s office.  A summary and comparison of the programs is presented in Table 1.

Table 1.  Studies reporting treatment strategies for opioid abuse amongst the homeless
Feature	Hall, et al., 2014	Daniels, et al., 2014	Tringale, et al., 2015
Target Population	Disenfranchised individuals (e.g. homeless, injection drug users and uninsured)	Clients of a community recovery center who were unsuccessful in recovery	Treatment-resistant poor, urban, heroin-dependentneedle exchange patients
Inclusion Criteria	Household income at or below 350% of the Federal Poverty LevelResident of New Jersey,History of injection drug use, Test positive for opioids, Not currently enrolled in opioid replacement therapyUninsured.	Opiate dependence (DSM-IV)	Current heroin useNeedle exchange enrollment
Exclusion Criteria	None specified	Already receiving medication-assisted treatment for opioid dependence	Positive methadone or benzodiazepine useHeavy alcohol use
Location	New Jersey (6 sites)	Baltimore, MD	Los Angeles, CA
Study Design	Prospective, Cohort	Retrospective, descriptive	Prospective, descriptive
Setting	Mobile medication units, including a syringe exchange service“Brick and mortar” methadone clinics	Community-based recovery center (Dee’s Place)	Community-based needle exchange program
Funding	Public funding Blood borne Disease Harm Reduction Act of 2006	Grant funded	Grant funded (NIH)
Available Treatments	Buprenorphine/naloxone or methadoneDetoxificationDiagnostic testingCase managementMental health servicesLittle to no charge to participants	Buprenorphine/naloxoneDaily meetings on recovery Weekly (Friday) meetings on relapse preventionPeer counselors No charge to participants	Buprenorphine (22-day course, including 15 days of detoxification) Peer support groupSubstance-abuse counselors
Abstinence Testing or Requirement	None	Testing – yesAbstinence Requirement – no 	Testing – yesAbstinence Requirement – no
Role of Homelessness in the Study	Homeless, injection drug users and uninsured were targeted populations	Program sought to provide service to people who could/would not otherwise access72% did not rent/own a home18% living in transitional/recovery housing	Targeted initiative of the Center for Harm Reduction of Homeless Healthcare Los Angeles
Authors’ Recommenda-tions	Need to address connection between correctional/criminal justice system and substance abusePublic funding addresses the barrier of affordability of treatmentIncrease number of treatment facilities and improve geographic access	Providing buprenorphine services at community-based recovery center can help increase available treatment optionsA community center-based buprenorphine program may hold promise for increasing access to and improving substance use outcomes among the most underserved.Consider partnerships between Substance Abuse and Mental Health Services Agency and Accountable Care Organizations and the communities they serve	Comprehensive, non-judgmental detoxification and harm reduction reduces treatment-resistant needle exchange patients reluctance to enroll in long-term maintenance therapies.Incorporate non-traditional settings into drug treatment as a way to enhance access to care and recovery for an underserved heroin-dependent population
3.1	The Mobile Medication Unit
Hall and colleagues sought to understand the barriers to MAT experienced by the severely disenfranchised, including the homeless, uninsured and low-income populations by conducting a prospective cohort study  ADDIN EN.CITE ().  Through legislative action in the state of New Jersey, funding was provided for medication therapy (i.e. participants were offered the choice of either methadone or buprenorphine) and a mobile medication unit (MMU) that made two stops per day, six times per week, at six sites across the state.  Each van was affiliated with a traditional office-based methadone clinic.  Areas for visitation were identified based on their high prevalence of HIV and injection drug users (IDUs), homeless and uninsured.  This community-based service was offered at little to no charge on a walk-in basis.  The MMUs were equipped and staffed to also provide sterile syringe exchange, blood borne disease and STD testing, cognitive behavioral therapy, case management and connections to and financial support for other substance abuse treatment.  Notably, case managers assisted participants with applying for Medicaid and provided counseling on employment and education opportunities.  The MMU clients were compared to those who utilized methadone MAT via the traditional office-based methadone clinic as well as those who received treatment at the same location but did not receive MAT.
Based upon clients enrolled between 2008 and 2010, compared to participants receiving MAT from a traditional clinic, MMU clients were older, more likely to be African American or Latino, have less social capital (i.e. less likely to be married and more likely to be homeless or uninsured), more likely to be IDU and have a diagnosis of mental illness.  The study also showed that of the 25% of clients that elected buprenorphine MAT, these clients were more likely to be African American, Latino and non-IDUs.
The recommendations of Hall et al. (2014) included increasing public funding to reduce barriers of affordability for treatment to the disenfranchised population, as well as to increase the number of available treatment facilities and geographic access.  The MMU system was able to provide outreach to a population greatly in need of treatment an otherwise virtually unable to obtain it.
3.2	A Community-Based Recovery Center
Bringing the services to the population was also described in a retrospective, descriptive study by Daniels, Salisbury-Afshar, Hoffberg, Agus and Figerhood in 2014, conducted at a site in Baltimore, MD known as “Dee’s Place.”  The aims of the study were to describe clients served by a buprenorphine program in a community-based recovery center and present initial treatment outcomes.  The goal was to engage the recovery center population in treatment and once stable and insured, transition them to continued treatment in a primary care setting.  
The unique feature of this program was the treatment’s colocation with the recovery center, which also hosted 12-Step meetings and connected participants with support services such as housing, legal assistance, health and mental health needs.  In this case, the staff of Dee’s Place had approached the local nonprofit Behavioral Health Leadership Institute about providing treatment services at the center.  While the primary goal of the center was not to provide treatment for opioid abuse, it nonetheless recognized that many people in the community were in need of services and would otherwise be unable to access them.  On a weekly basis a team of a physician, nurses, counselors, a case manager and community outreach worker made contact with each participant at Dee’s Place.  Prescriptions for up to a week’s take-home supply of buprenorphine/naloxone were paid for by grant funding and provided to participants free of charge.  
Other features of the treatment program included daily to weekly contact with a nurse or case manager, urine drug screening, daily Narcotics Anonymous meetings as well as weekly relapse prevention meetings.  While urine drug screens were monitored for the presence of buprenorphine and opiates, abstinence was not a requirement of continuation in the program; rather, the presence of opioids in the participant’s urine indicated to the clinical team that he or she needed additional support.  For this reason, Dee’s Place provided “recovery coaching” through a team of counselors who have received additional training by the state-funded Baltimore Substance Abuse Services agency.  Outcome measures included buprenorphine adherence and opiate abstinence.  A successful participant obtained health insurance and established continued treatment with a community primary care provider.
Demographics from the Daniels, et al. (2014) study indicate that among the 78 individuals from that population who received treatment, 78% were African American and 55% were males.  Approximately 72% did not own or rent their own home, 18% of whom were living in transitional or recovery housing.  Overall, the average length of treatment for all clients was 13.5 weeks, during which the mean percent of opiate-abstinent weeks was 83% and buprenorphine-adherent weeks was 95%.  Approximately half of all participants were successfully transitioned to primary care-based treatment, with no statistically significant differences between those who transitioned and those who did not.  Successfully transitioned clients did, however, have a significantly longer time in treatment than those who did not, with respective means of 20.5 weeks versus 6.9 weeks.
Daniels, et al. (2014) arrived at the conclusion that treatment needs to be provided in the areas of need.  Buprenorphine programs are less restrictive than those to operate a methadone clinic, thus may be a practical option to in these settings.  Treatment services at a recovery center were able to access a marginalized group of people who were identified by their own community.
3.3	The Needle Exchange Program
Following publication of the Daniels, et al. (2014) study, a group of Los Angeles colleagues submitted a letter to the editor of the Journal of Addiction Medicine  ADDIN EN.CITE ().  A non-traditional drug treatment center, the Center for Harm Reduction of Homeless Healthcare Los Angeles sought to help treatment-resistant, poor, urban, heroin-dependent patients transition to opioid maintenance therapy as a harm reduction strategy.  As a pilot study with nine patients, Tringale et al. sought to identify the potential for a program that appealed to this population based on its non-judgmental philosophy and acceptance of relapse, 15-day buprenorphine detoxification supported by peers and daily provider dispensed dosing and certified substance abuse counselors.  Participants were identified through a local needle exchange program.  Of note, patients who tested positive for benzodiazepine use were excluded from the study, due to risk of overdose.
Of the seven patients who completed the 22-day program, six were successfully transitioned to long-term MAT.  Participants reported that the ability for buprenorphine to reduce cravings and stabilize cognition and emotional processing, permitted use of opiates and illicit substances and long-term treatment goal planning were strengths of the program.  The investigators openly acknowledged the size of their study as a significant limitation.

4.0 	Discussion
Many aspects of the three programs previously described are consistent with recommendations put forth by Health Care for the Homeless Clinicians’ Network (2014), developed with support from the Bureau of Primary Health Care, Health Resources and Services Administration and U.S. Department of Health and Human Services.  This review presented several important themes to designing a public health approach to offer treatment for opioid abuse to the homeless, including the use of unconventional treatment sites, offering MAT and utilizing a harm reduction approach to establish housing.    As part of the evaluation for any intervention, consideration is also given to funding of these programs.
4.1	Unconventional Treatment sites
The most salient feature of these three programs was their novel approach to providing treatment to a marginalized population through unconventional treatment sites.  Both the Assistant Surgeon General’s 1999 report on Principles of Practice, A Clinical Resource Guide for Health Care for the Homeless () as well as the 2014 report from the Health Care for the Homeless Clinicians’ Network guide Adapting Your Practice: Recommendations for the Care of Homeless Patients with Opioid Use Disorders () support utilization of community-based models for the treatment of opioid addiction among the homeless.  The programs featured here established treatment in areas where the homeless were known to be found and by doing so, each program found a way to bring services to people who otherwise did not have the resources to seek treatment or feel comfortable in a traditional office or clinic setting.  
4.2	Provision of mat
All three programs included in this review also made use of MAT.  This is consistent with guidelines developed by agencies of the federal and Pennsylvania government to guide clinicians and healthcare advocates to take on the opioid epidemic  ADDIN EN.CITE (; ; ).  All three of the programs described herein offered treatment with buprenorphine; only Hall et al. (2014) additionally offered methadone.  Despite their lack of stable housing, the clinicians and research teams involved felt that under supervision and with evidence-based behavioral therapies, MAT is a safe and cost-effective manner of treating opioid and heroin substance use disorders.  
4.3	harm reduction approach to housing
The third theme of these programs was taking a harm reduction approach to establishing housing for people seeking recovery.  Doing so acknowledges the complexity and resources that must be involved to overcome homelessness and opioid abuse.  While Daniels, et al. (2014) and Tringale, et al. (2015) incorporate drug screening as part of their protocols, relapse did not exclude people or result in dismissal from the program; rather, it was used to identify individuals who needed additional support.  
This is important to consider when assessing treatment programs available to the homeless of western Pennsylvania.  In AC alone there were over 1,500 homeless individuals (excluding those in permanent supportive housing), 93% of whom had access to shelter (i.e. a primary nighttime residence that is a supervised shelter designed to provide temporary living accommodations, including both emergency shelters and transitional housing) ().  While considered shelter, it is unclear whether these provide sufficient stability and security to foster recovery from opioid abuse.  Furthermore, while AC has a capacity of approximately 1,000 beds in transitional or permanent supportive housing, for some, mandatory abstinence restricts access to initial or continued housing if a person should relapse (; ).  Therein lays the advantage of the three programs previously described: their ability to provide treatment despite the lack of stable housing.
As part of a preliminary assessment of services for the homeless in AC, focus groups with clients of the AC homelessness service system revealed that strict “clean-time” and background check requirements made it difficult to find a housing program ().  The importance of changing this experience was supported by the Pennsylvania Department of Drug and Alcohol Programs in their 2014-2015 strategic plan, which outlined the need to expand access to and availability of resources to support homeless with substance use disorders ().  A number of agencies have also endorsed program guidelines that also services such as the management of concurrent physical and mental health issues as well as employment services  ADDIN EN.CITE (; ; ).  This comprehensive approach addresses the complicating factors that make recovery from opioid abuse especially difficult for the homeless.  
4.4	program Funding and expansion
Implementation of all three programs described by Hall et al. (2014), Daniels et al. (2014) and Tringale et al. (2015) was supported by public or grant funding.  Identification of new funding streams will be critical for successful implementation of new programs or expansion of existing programs in AC, which may include receipt of federal grants.  Encouraging statements by the federal government have suggested that several regulatory changes and funding opportunities are on the horizon.  Health and Human Services Secretary Sylvia Burwell announced the agency’s plans to revise Federal regulations in order to expand access to buprenorphine treatment as well as award $1.8 million in grants to support community partnerships, including facilitating referrals to substance abuse centers ().  Previous research has presented a number of reasons why chronic heroin users put off seeking health care, which may contribute to inappropriate use of the emergency departments ().  Hospitals and emergency departments therefore may be suitable environments to help identify individuals ready to accept treatment and connect them to community services ().  
With increasing numbers of programs and increasing referrals to programs, the demand for funding will consequentially increase.  Financial support to provide MAT for the homeless will need included in any program proposal.  Pennsylvania’s Medicaid program presently covers both buprenorphine and methadone for those that are enrolled (); however, not all homeless may be enrolled.  Despite the efforts of the Affordable Care Act, data from the 2014 National Health Care for the Homeless Program suggest that 43.1% of homeless patients are uninsured; this may in fact an underestimate, as it was based solely on patients presenting to the Health Care for the Homeless programs ().  
Fortunately, AC already has a number of organizations to effect positive change in opioid abuse among the homeless in AC (Appendix A). At present, organizations such as Prevention Point Pittsburgh, Familylinks and Operation Safety Net are already operational and providing health interventions to the homeless.  Leveraging their established relationships with the homeless community and expanding provision of MAT, possibly by developing novel outreach efforts like the three presented here, will be an essential part of the public health strategy for treating the opioid epidemic.
5.0 	conclusion
The magnitude of opioid abuse has reached epidemic levels as national survey data reveal that 4.5 million people across the country abuse medications intended for pain relief.  Especially hard hit, all counties of southwestern Pennsylvania exceed the state’s mortality rate for deaths due to prescription drugs.  The co-occurrence of substance abuse and homelessness has already been well established.  As the homeless population of AC has increased, research that indicates drug overdoses have replaced HIV/AIDS as the leading cause of mortality among the homeless, with 80% of overdose deaths attributable to opioids, warrants concern.  This article presents a review of treatment options for the homeless population with opioid use disorder which may be feasible to offer before securing housing, based upon recently published literature.  
A search of PubMed has produced three studies published in the last five years on unique programs.  Lessons gained from these programs demonstrate the importance of designing a public health approach to offer treatment for opioid abuse to the homeless, including the use of unconventional treatment sites, offering MAT and utilizing a harm reduction approach to establish housing.  As the number of programs available and referral and utilization of the programs increase, special consideration should also be given to sources of funding.  While the design of this review captures only three studies, future research should continue to examine social ecological influences on homelessness and opioid abuse to identify feasible interventions.  Healthcare stakeholders must consider the importance of complex social ecological factors when determining how to address this epidemic and its disturbing financial and humanistic costs.  
The most prominent limitation of this review is the capture of only three publications in the last five years.  This may be attributable to the search methodology described, as utilized in PubMed.  While homelessness is often reported as a demographic factor, this review was dependent upon the term “homeless” as part of its search parameter.  The review also targeted studies specifically aimed at the homeless.  It is likely that a variety of other treatment strategies may be adaptable to this population, although they have not been published as being focused on the homeless.  The search was also limited to English-only articles.  Other indexed databases of research may also provide additional relevant articles. 
Future investigation should continue to follow the social ecological model to identify successful methods of treatment, as this public health problem is far too large and complex to be solved at any one level alone.  Directly involving peers of the homeless and recovered formerly homeless individuals in the design of interventions, as Daniels et al. (2014) and Tringale et al. (2015) did, would be beneficial as they can draw upon their own experiences and relationships with this community. The qualitative research by McNeil et al. (2015) demonstrates the insights that can be gained through semi-structured interviews in order to better understand the perspective of this population.  Both of these approaches will help to develop feasible interventions that are culturally sensitive to the homeless population.
The potential financial and humanistic costs of healthcare stakeholders failing to respond to this epidemic are perhaps most unsettling.  Prescription opioid abuse, dependence and misuse were estimated to have incurred societal costs estimated at $55.7 billion from 2003 to 2007 alone (Birnbaum et al., 2011).  Left unaddressed, at current mortality rates, 44 people across the nation will continue to die on a daily basis due to opioid overdose (Centers for Disease Control and Prevention, 2015).  When developing interventions to address the epidemic, public health advocates and clinicians must remember that it will not be a model of “one size fits all”; rather, applying the social ecological model to understand complex factors and design community-oriented approaches will be critical to reigning in the costs of abuse and reaching even the most marginalized members of society.  
Healthcare stakeholders must consider again the findings presented by Baggett et al. (2013), demonstrating that drug overdose, particularly related to opioid analgesics and heroin, has replaced HIV/AIDS as the leading cause of death of homeless adults.  Advances in antiviral medicine have transformed HIV/AIDS from a deadly condition into a chronic disease state, making it possible for many, including the homeless, to live longer, healthier lives.  Yet it seems cruelly ironic that substance abuse, including opioid medications, has now become their primary cause of mortality.
APPENDIX a: Example resources in allegheny county 
Operation Safety Net
Website:  https://www.pmhs.org/operation-safety-net/ (​https:​/​​/​www.pmhs.org​/​operation-safety-net​/​​)

Purpose:  As long as there are unsheltered homeless sleeping on our streets, in our abandoned buildings, and along our riverbanks, Operation Safety Net will provide access to health care that is designed to meet their unique needs. Program activities include:
	Street Outreach:  Walking teams of clinicians and formerly homeless workers provide care in the streets.
	Case Management:  Patients are given a supportive environment to help them plan their own recovery.
	Computerized Database:  OSN is a pioneer in applying information technology with health care treatment.
	Medical Services Mobile Van:  The van is a physician's office on wheels that travels to distressed areas afflicted by poverty, drugs and crime.
	WellSpring Drop-in Clinic:  Primary care services, free of charge, are provided in a physician office complex.
	Medical Education:  OSN trains future physicians and clinicians to provide care to the poor.
	Projects:  OSN builds community through public health partnerships, housing connections, research studies, and local as well as national leadership roles.


Prevention Point Pittsburgh 
Website:  www.pppgh.org/services (​http:​/​​/​www.pppgh.org​/​services​) 

Prevention Point Pittsburgh (PPP) is a nonprofit organization dedicated to providing health empowerment services to injection drug users.





Website:  www.familylinks.org (​http:​/​​/​www.familylinks.org​)

	Penn Free Bridge Housing:  Penn Free Bridge Housing offers secure housing to people ages 18 and older who are homeless and in recovery from alcohol or drug abuse, who have been referred via Allegheny Link. The program provides:
o	Secure, financially-supported accommodations for individuals and/or families for up to one year
o	Supportive services in areas such as employment, education, counseling, legal issues, medical support and household needs
o	Bus tickets and passes as needed
o	Assurance of recovery program, including random urine tests
	To qualify for admission to Penn Free Bridge Housing, individuals must be:
o	18 years or older
o	Earning less than 200% of the federal poverty guideline limit
o	Homeless by County definition and referred via the Allegheny Link housing list
o	Chemical-free for a minimum of 90 days
o	In treatment for substance abuse, or actively involved in recovery

	Shelter Plus Care Program:  Familylinks realizes that some people need support on an ongoing basis. Shelter Plus Care Program provides permanent housing and case management services for people and families that are homeless and have disabilities, including mental health issues and/or substance abuse.
	Federally funded by the Department of Housing and Urban Development, Shelter Plus Care may subsidize up to 100% of rent, depending on an individual's income.
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